JP2018532412A5 - - Google Patents

Download PDF

Info

Publication number
JP2018532412A5
JP2018532412A5 JP2018522565A JP2018522565A JP2018532412A5 JP 2018532412 A5 JP2018532412 A5 JP 2018532412A5 JP 2018522565 A JP2018522565 A JP 2018522565A JP 2018522565 A JP2018522565 A JP 2018522565A JP 2018532412 A5 JP2018532412 A5 JP 2018532412A5
Authority
JP
Japan
Prior art keywords
gene
promoter
butyrate
bacteria
bacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018522565A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018532412A (ja
Filing date
Publication date
Priority claimed from US14/998,376 external-priority patent/US20160206666A1/en
Priority claimed from PCT/US2016/020530 external-priority patent/WO2016141108A1/en
Application filed filed Critical
Priority claimed from PCT/US2016/050836 external-priority patent/WO2017074566A1/en
Publication of JP2018532412A publication Critical patent/JP2018532412A/ja
Publication of JP2018532412A5 publication Critical patent/JP2018532412A5/ja
Priority to JP2021192519A priority Critical patent/JP2022033832A/ja
Pending legal-status Critical Current

Links

JP2018522565A 2015-10-30 2016-09-08 消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌 Pending JP2018532412A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021192519A JP2022033832A (ja) 2015-10-30 2021-11-26 消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US201562248814P 2015-10-30 2015-10-30
US201562248805P 2015-10-30 2015-10-30
US201562248825P 2015-10-30 2015-10-30
US62/248,814 2015-10-30
US62/248,825 2015-10-30
US62/248,805 2015-10-30
US201562256042P 2015-11-16 2015-11-16
US201562256044P 2015-11-16 2015-11-16
US201562256048P 2015-11-16 2015-11-16
US62/256,042 2015-11-16
US62/256,044 2015-11-16
US62/256,048 2015-11-16
US14/998,376 2015-12-22
US14/998,376 US20160206666A1 (en) 2014-12-22 2015-12-22 Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
US201662291461P 2016-02-04 2016-02-04
US201662291470P 2016-02-04 2016-02-04
US201662291468P 2016-02-04 2016-02-04
US62/291,470 2016-02-04
US62/291,461 2016-02-04
US62/291,468 2016-02-04
USPCT/US2016/020530 2016-03-02
PCT/US2016/020530 WO2016141108A1 (en) 2015-03-02 2016-03-02 Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
PCT/US2016/050836 WO2017074566A1 (en) 2015-10-30 2016-09-08 Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021192519A Division JP2022033832A (ja) 2015-10-30 2021-11-26 消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌

Publications (2)

Publication Number Publication Date
JP2018532412A JP2018532412A (ja) 2018-11-08
JP2018532412A5 true JP2018532412A5 (cg-RX-API-DMAC7.html) 2019-10-17

Family

ID=58630598

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018522565A Pending JP2018532412A (ja) 2015-10-30 2016-09-08 消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌
JP2021192519A Pending JP2022033832A (ja) 2015-10-30 2021-11-26 消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021192519A Pending JP2022033832A (ja) 2015-10-30 2021-11-26 消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌

Country Status (6)

Country Link
US (1) US20240110192A1 (cg-RX-API-DMAC7.html)
EP (2) EP3368696A1 (cg-RX-API-DMAC7.html)
JP (2) JP2018532412A (cg-RX-API-DMAC7.html)
AU (2) AU2016346646B2 (cg-RX-API-DMAC7.html)
CA (1) CA3002965A1 (cg-RX-API-DMAC7.html)
WO (1) WO2017074566A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3711488A1 (en) 2015-05-06 2020-09-23 Snipr Technologies Limited Altering microbial populations & modifying microbiota
WO2016210384A2 (en) 2015-06-25 2016-12-29 Synlogic, Inc. Bacteria engineered to treat metabolic diseases
WO2017123418A1 (en) * 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat metabolic diseases
ES3018615T3 (es) * 2018-04-13 2025-05-16 Superbrewed Food Inc Un ingrediente para pienso que comprende Clostridium tyrobutyricum
EP3920908A4 (en) * 2019-02-08 2022-10-05 McMaster University USE OF HYDROCARBON RECEPTOR ACTIVATORS IN THE TREATMENT OF GLUTEN-INDUCED GASTROINTESTINAL DISEASES
KR20220003030A (ko) 2019-04-29 2022-01-07 신로직 오퍼레이팅 컴퍼니, 인코포레이티드 살아 있는 세포 계수 기술에 의한 유전적으로 조작된 미생물의 계수
JP7620575B2 (ja) * 2019-06-13 2025-01-23 ダンマークス テクニスク ユニバーシテット インビボでセロトニンを産生するように設計された高度な微生物叢治療薬
CA3181432A1 (en) * 2020-06-16 2021-12-23 Yoon-Keun Kim Composition for preventing or treating neurological or mental disorders comprising vesicles derived from lactobacillus paracasei
CN111995767B (zh) * 2020-08-20 2022-02-15 齐鲁工业大学 改性腐植酸钠和制备方法及应用
EP4256039A2 (en) 2020-12-02 2023-10-11 Synlogic Operating Company, Inc. Engineered microorganisms
CN113046259B (zh) * 2020-12-29 2022-03-15 亳州学院 一株产4-甲基苯酚的第三梭菌及其应用
CN112625963B (zh) * 2020-12-29 2022-03-18 亳州学院 一株产4-甲基苯酚的煎盘梭菌及其应用
CN112877271B (zh) * 2021-02-05 2023-03-14 江西师范大学 一种提高钝齿棒杆菌厌氧发酵产l-精氨酸的方法
WO2022184637A1 (en) * 2021-03-01 2022-09-09 Evonik Operations Gmbh Preparations comprising probiotic strains and l-tryptophan
CN115637246A (zh) * 2021-07-19 2023-01-24 中国科学院深圳先进技术研究院 一种抑菌用工程菌及其制备方法和应用
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
CN114891705B (zh) * 2022-07-11 2022-09-16 东北农业大学 一种产酸的民猪源罗伊氏乳杆菌及其培养方法与应用
GB202402011D0 (en) 2024-02-14 2024-03-27 Snipr Biome Aps A novel type of crispr/cas system
CN118955660A (zh) * 2024-07-13 2024-11-15 扬州大学 一种普雷沃氏菌的寡肽转运蛋白及其应用
CN119120262A (zh) * 2024-08-12 2024-12-13 济南微生态生物医学省实验室 一株植物乳植杆菌jnl0074、其应用以及一种微生物菌剂
CN119818485A (zh) * 2025-02-27 2025-04-15 江南大学 化合物吲哚丙烯酸在制备用于调控肠上皮坏死性凋亡防治新生儿坏死性小肠结肠炎的药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
EP0288451B1 (en) * 1987-04-23 1994-08-10 Monsanto Company Secretion of insulin-like growth factor 1 in E. coli
US5264365A (en) * 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
AU3108400A (en) 1998-12-02 2000-06-19 Trustees Of Boston University Gene networks for control of gene expression
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US7731976B2 (en) 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
EP1931770A4 (en) * 2005-10-07 2009-11-25 Univ California NUCLEIC ACIDS CODING FOR MODIFIED CYTOCHROM P450 ENZYME AND METHOD OF USE THEREOF
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
DE102008063900A1 (de) * 2008-12-19 2010-06-24 Wacker Chemie Ag Verfahren zur fermentativen Herstellung von heterologen Proteinen mittels Escherichia coli
WO2011036455A1 (en) * 2009-09-24 2011-03-31 Ucb Pharma S.A. Bacterial strain for recombinant protein expression, having protease deficient degp retaining chaperone activity, and knocked out tsp and ptr genes
EP2655624B1 (en) 2010-12-23 2017-11-29 Biogen MA Inc. Linker peptides and polypeptides comprising same
CN103834676B (zh) * 2014-02-28 2016-12-07 中国科学院福建物质结构研究所 一种大肠杆菌分泌表达外源蛋白的质粒载体及其构建方法

Similar Documents

Publication Publication Date Title
US20230043588A1 (en) Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
US20240110192A1 (en) Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
US11384359B2 (en) Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
US11685925B2 (en) Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
JP2018532412A5 (cg-RX-API-DMAC7.html)
US12545886B2 (en) Bacteria for the treatment of disorders
US11896627B2 (en) Bacteria engineered to treat metabolic diseases
JP7494345B2 (ja) 高フェニルアラニン血症を低減させるように操作された細菌
AU2017213646A1 (en) Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
US20210161976A1 (en) Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
WO2017123610A2 (en) Bacteria engineered to detoxify deleterious molecules
WO2017139708A1 (en) Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
EP3313371A2 (en) Bacteria engineered to treat metabolic diseases